RU2016139409A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016139409A3 RU2016139409A3 RU2016139409A RU2016139409A RU2016139409A3 RU 2016139409 A3 RU2016139409 A3 RU 2016139409A3 RU 2016139409 A RU2016139409 A RU 2016139409A RU 2016139409 A RU2016139409 A RU 2016139409A RU 2016139409 A3 RU2016139409 A3 RU 2016139409A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1418—Threaded type
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Packages (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014046903 | 2014-03-10 | ||
JP2014-046903 | 2014-03-10 | ||
PCT/JP2015/056985 WO2015137326A1 (fr) | 2014-03-10 | 2015-03-10 | Procédé pour stabiliser le dibutylhydroxytoluène |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2016139409A RU2016139409A (ru) | 2018-04-10 |
RU2016139409A3 true RU2016139409A3 (fr) | 2018-09-26 |
RU2690490C2 RU2690490C2 (ru) | 2019-06-04 |
Family
ID=54071770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2016139409A RU2690490C2 (ru) | 2014-03-10 | 2015-03-10 | Способ стабилизации дибутилгидрокситолуола |
Country Status (5)
Country | Link |
---|---|
JP (2) | JP6509811B2 (fr) |
CN (1) | CN106068122B (fr) |
RU (1) | RU2690490C2 (fr) |
TW (1) | TWI644663B (fr) |
WO (1) | WO2015137326A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI644663B (zh) * | 2014-03-10 | 2018-12-21 | 日商千壽製藥股份有限公司 | 二丁基羥基甲苯的穩定化方法,及含二丁基羥基甲苯之製品(一) |
WO2015190483A1 (fr) * | 2014-06-10 | 2015-12-17 | ロート製薬株式会社 | Composition acqueuse destinée à un usage ophtalmique |
JP2017105752A (ja) * | 2015-08-31 | 2017-06-15 | ロート製薬株式会社 | 眼科組成物 |
JPWO2017043488A1 (ja) * | 2015-09-08 | 2018-06-28 | ロート製薬株式会社 | 眼科組成物 |
CN112533636A (zh) * | 2018-05-31 | 2021-03-19 | 千寿制药株式会社 | 抑制二丁羟基甲苯含量降低的眼科用液体制剂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE297206T1 (de) * | 1994-03-15 | 2005-06-15 | Senju Pharma Co | Verfahren zur stabilisierung von pranoprofen und stabile flüssige zubereitung von pranoprofen |
JP4831944B2 (ja) * | 2004-04-28 | 2011-12-07 | ロート製薬株式会社 | プラノプロフェン含有組成物 |
JP4989898B2 (ja) * | 2005-01-26 | 2012-08-01 | ロート製薬株式会社 | プラノプロフェン含有組成物 |
JP2007099697A (ja) * | 2005-10-05 | 2007-04-19 | Rohto Pharmaceut Co Ltd | プラノプロフェン及びクロモグリク酸塩含有点眼剤 |
JP6009141B2 (ja) * | 2009-10-09 | 2016-10-19 | ロート製薬株式会社 | 水性組成物 |
JP5729991B2 (ja) * | 2009-12-02 | 2015-06-03 | ロート製薬株式会社 | シリコーンハイドロゲルコンタクトレンズ用眼科組成物 |
US9145295B2 (en) * | 2011-07-12 | 2015-09-29 | The University of Houston Systems | Ultra-fast suspended graphene nano-sensors suitable for large scale production |
WO2013099861A1 (fr) * | 2011-12-27 | 2013-07-04 | 千寿製薬株式会社 | Préparation contenant du dibutylhydroxytoluène et procédé destiné à la stabilisation du dibutylhydroxytoluène |
TWI644663B (zh) * | 2014-03-10 | 2018-12-21 | 日商千壽製藥股份有限公司 | 二丁基羥基甲苯的穩定化方法,及含二丁基羥基甲苯之製品(一) |
-
2015
- 2015-03-09 TW TW104107429A patent/TWI644663B/zh not_active IP Right Cessation
- 2015-03-10 CN CN201580012544.2A patent/CN106068122B/zh active Active
- 2015-03-10 JP JP2016507754A patent/JP6509811B2/ja active Active
- 2015-03-10 WO PCT/JP2015/056985 patent/WO2015137326A1/fr active Application Filing
- 2015-03-10 RU RU2016139409A patent/RU2690490C2/ru active
-
2019
- 2019-04-03 JP JP2019071483A patent/JP6800264B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CN106068122B (zh) | 2019-04-19 |
RU2016139409A (ru) | 2018-04-10 |
WO2015137326A1 (fr) | 2015-09-17 |
TW201617056A (zh) | 2016-05-16 |
RU2690490C2 (ru) | 2019-06-04 |
TWI644663B (zh) | 2018-12-21 |
CN106068122A (zh) | 2016-11-02 |
JP6509811B2 (ja) | 2019-05-08 |
JP2019147802A (ja) | 2019-09-05 |
JP6800264B2 (ja) | 2020-12-16 |
JPWO2015137326A1 (ja) | 2017-04-06 |